paliperidone palmitate
paliperidone palmitate is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including INVEGA TRINZA, Erzofri extended-release, INVEGA HAFYERA. Available dosage forms: injection, suspension, extended release, injection.
Drug details
- Generic Name
- paliperidone palmitate
- Brand Names
- INVEGA TRINZA, Erzofri extended-release, INVEGA HAFYERA, INVEGA SUSTENNA
- Application Number
- NDA207946
- Sponsor
- Janssen Pharmaceuticals, Inc
- NDC Codes
- 17
- Dosage Forms
- INJECTION, SUSPENSION, EXTENDED RELEASE, INJECTION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- PALIPERIDONE PALMITATE
Indications and Usage
1 INDICATIONS AND USAGE ERZOFRI is indicated for the treatment of: Schizophrenia in adults . Schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants . ERZOFRI is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 ) Treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. ( 1 )